| Title |
Huperzine A for mild cognitive impairment
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2012
|
| DOI | 10.1002/14651858.cd008827.pub2 |
| Pubmed ID | |
| Authors |
Jirong Yue, Bi Rong Dong, Xiufang Lin, Ming Yang, Hong Mei Wu, Taixiang Wu |
| Abstract |
Mild cognitive impairment (MCI) has been proposed as a condition of intermediate symptomatology between the cognitive changes of ageing and fully developed symptoms of dementia. Treatment in the stages of MCI may delay the deterioration of cognitive impairment and delay the progression to dementia. Currently, the treatments for Alzheimer's disease have been focused on increasing acetylcholine levels in the brain. However, these drugs have not been proven to be effective for MCI and have numerous side effects. Huperzine A may have some beneficial effects in MCI. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Korea, Republic of | 1 | <1% |
| India | 1 | <1% |
| Unknown | 174 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 11% |
| Student > Bachelor | 19 | 11% |
| Researcher | 17 | 10% |
| Student > Ph. D. Student | 16 | 9% |
| Student > Postgraduate | 14 | 8% |
| Other | 30 | 17% |
| Unknown | 60 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 21% |
| Psychology | 21 | 12% |
| Nursing and Health Professions | 15 | 9% |
| Agricultural and Biological Sciences | 6 | 3% |
| Neuroscience | 5 | 3% |
| Other | 22 | 13% |
| Unknown | 70 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2022.
All research outputs
#2,635,651
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#5,238
of 13,140 outputs
Outputs of similar age
#24,156
of 288,465 outputs
Outputs of similar age from Cochrane database of systematic reviews
#73
of 195 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,465 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.